From: The management of heart failure cardiogenic shock: an international RAND appropriateness panel
Statements | Median | Disagreement index (DI) | Inter-percentile range (IPR) | RAND panel outcome |
---|---|---|---|---|
Please rate the appropriateness of the following in the initial assessment and management of SCAI Stage C HF-CS: | ||||
Focussed Cardiac Ultrasound | 9 | 0.13 | 1.00 | Appropriate |
Pulmonary artery catheter | 6 | 0.51 | 2.00 | Uncertain |
Point of care thoracic ultrasound | 5 | 1.27 | 4.00 | Uncertain |
Point of care Abdominal Ultrasound | 3.5 | 0.35 | 2.25 | Uncertain |
Norepinephrine as 1st line vasopressor | 7 | 0.16 | 1.00 | Appropriate |
Dopamine as 1st line vasopressor | 3.5 | 0.51 | 2.25 | Uncertain |
Dobutamine as 1st line inotrope | 6.5 | 0.35 | 2.25 | Appropriate |
Milrinone as 1st line inotrope | 6 | 0.51 | 2.00 | Uncertain |
Shock team discussion in patients suitable for escalation to tMCS | 8 | 0.29 | 2.00 | Appropriate |
Application of prognostic scoring tools e.g. IHVI and CardShock to inform management and escalation | 4 | 0.51 | 2.00 | Uncertain |